A total of 13 products were added in the month from ninedifferent asset managers: Fisch AM, Lord Abbet, Aktia, Pictet, PIMCO, Robeco, JP Morgan, Lindsay Goldberg and Manulife.
CCR Monthly Approval Report – July 2019
August 2, 2019 by
A total of 28 products were added in the month from nine different asset managers: Amundi, Barings, BlueBay, Cathay, Fidelity, Janus Henderson, Principal, IK Investment Partners, Singuler Guff.
CCR Monthly Approval Report – March 2019
April 8, 2019 by
iShares led with ten ETFs registered, while Franklin Templeton, AllianceBernstein and Baillie Gifford won approval for their mutual fund products. The CCR also approved five alternatives products from BlackRock, Morgan Stanley, Oak Hill, Portfolio Advisors, and Tikehau Capital.
CCR Monthly Approval Report – June 2019
July 1, 2019 by
A total of 29 products were added in the month from nine different asset managers: iShares, Amundi, MainFirst, Jupiter, MFS, GAM, JP Morgan, Bci and Lyxor.
CCR Monthly Approval Report – February 2019
March 6, 2019 by
A total of 14 products were added in the month from 10 different asset managers: Investec, Man, Sycomore, Sinergy, Ardian, CVC, Oak, PGIM, and Global Infrastructure Partners.
CCR Monthly Approval Report – January 2019
February 25, 2019 by
Jupiter, Invesco, Pictet, Franklin Templeton (ETF), L&G (ETF), Bain (Alternative) and StepStone (Alternative) were the managers registering products in January 2019.
CCR Monthly Approval Report – May 2019
June 3, 2019 by
JP Morgan led with eight ETFs registered in the month, while Lyxor (4), M&G (2), Amundi (1), Comgest (1), HSBC (1) and Angelo Gordon (1) won approval for their products.
CCR Monthly Approval Report – September 2019
October 7, 2019 by
Amundi, Axa, Court Square, DWS, Eurizon, First Trust, Hayfin, Lazard, Man, UBS were the fund sponsors gaining approval for new products in September.
CCR Monthly Approval Report – April 2019
May 3, 2019 by
iShares led with 11 ETFs registered in the month, while M&G followed with five mutual funds. Invesco, Nordea,Baillie Gifford, and Vontobel, joined the list along with four alternatives products.
CCR Monthly Approval Report – December 2018
January 7, 2019 by
Products from BNP Paribas, Lyxor, Fidelity, Amundi and Man won approval, as did Avenue Capital Group to offer its alternative products.
